NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

ResMed Inc (ASX: RMD)

 
RMD Technical Analysis
5
As on 1st Nov 2017 RMD Share Price closed @ 11.12 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 9.39 & Strong Buy for SHORT-TERM with Stoploss of 9.85 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

RMD Share Price

Open 10.98 Change Price %
High 11.16 1 Day 0.29 2.68
Low 10.96 1 Week 0.00 0.00
Close 11.12 1 Month 1.19 11.98
Volume 3029242 1 Year 3.23 40.94
52 Week High 11.16 | 52 Week Low 7.62
 
ASX Australia Most Active Stocks
COE 0.30 3.45%
GPP 0.02 0.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
AGO 0.02 0.00%
BPT 1.05 7.14%
PNX 0.01 0.00%
PIO 0.03 0.00%
DJS 3.99 0.00%
KSO 0.40 3900.00%
 
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
XST 0.02 100.00%
XST 0.02 100.00%
ATP 0.03 50.00%
ATP 0.03 50.00%
PMQ 0.03 50.00%
RMI 0.03 50.00%
RMI 0.03 50.00%
BNV 0.03 50.00%
IRM 0.03 50.00%
 
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
GDY 0.01 -50.00%
 
 
RMD
Daily Charts
RMD
Intraday Charts
Whats New @
Bazaartrend
RMD
Free Analysis
 
RMD Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE11.31
RESISTANCE11.23
SUPPORT11.01
SUPPORT10.93
SUPPORT0.00
SUPPORT0.00
 
RMD Target for Month February
4th UP TARGET13.55
3rd UP TARGET12.68
2nd UP TARGET12.14
1st UP TARGET11.6
1st DOWN TARGET10.06
2nd DOWN TARGET9.52
3rd DOWN TARGET8.98
4th DOWN TARGET8.11
 
RMD Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
RMD Target for Year 2021
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
RMD Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website >
 
RMD Address
RMD
9001 Spectrum Center Boulevard
San Diego, CA 92123
United States
Phone: 858-836-5000
Fax: 858-836-5501
 
RMD Latest News
 
Your Comments and Response on ResMed Inc
 
RMD Business Profile
ResMed Inc., through its subsidiaries, engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. It offers various products, including airflow generators, diagnostic products, mask systems, headgear products, and ventilation devices for the treatment of sleep-disordered breathing that includes obstructive sleep apnea and other respiratory disorders, as well as other optional accessories, such as cold passover humidifiers, carry bags, and breathing circuits. The company also provides data communications and control products consisting of EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators, as well as humidifiers, which connect with the continuous and variable positive airway pressure, and autoset flow generators. ResMed Inc. markets its products to sleep clinics, home healthcare dealers, and third-party payers. The company sells its products through a network of distributors and direct sales force in approximately 100 countries worldwide. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
 
2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service